tiprankstipranks
Trending News
More News >
Ardent Health Partners, Inc. (ARDT)
NYSE:ARDT
US Market

Ardent Health Partners, Inc. (ARDT) Stock Forecast & Price Target

Compare
69 Followers
See the Price Targets and Ratings of:

ARDT Analyst Ratings

Strong Buy
9Ratings
Strong Buy
7 Buy
2 Hold
0 Sell
Based on 9 analysts giving stock ratings to
Ardent
Health Partners, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ARDT Stock 12 Month Forecast

Average Price Target

$20.17
▲(39.30%Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Ardent Health Partners, Inc. in the last 3 months. The average price target is $20.17 with a high forecast of $24.00 and a low forecast of $18.00. The average price target represents a 39.30% change from the last price of $14.48.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","18":"$18","25":"$25","14.5":"$14.5","21.5":"$21.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$20.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,14.5,18,21.5,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.59,13.467692307692307,14.345384615384615,15.223076923076922,16.10076923076923,16.978461538461538,17.856153846153845,18.73384615384615,19.611538461538462,20.48923076923077,21.366923076923076,22.244615384615386,23.122307692307693,{"y":24,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.59,13.173076923076923,13.756153846153847,14.33923076923077,14.922307692307694,15.505384615384617,16.08846153846154,16.67153846153846,17.254615384615384,17.837692307692308,18.42076923076923,19.003846153846155,19.586923076923078,{"y":20.17,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.59,13.006153846153847,13.422307692307692,13.838461538461539,14.254615384615384,14.670769230769231,15.086923076923076,15.503076923076923,15.919230769230769,16.335384615384616,16.751538461538463,17.167692307692306,17.583846153846153,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.3,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.3,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.97,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.97,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.83,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.91,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.7,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.35,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.08,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.66,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.97,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.59,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$24.00Average Price Target$20.17Lowest Price Target$18.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ARDT
TipRanks AITipRanks
Not Ranked
TipRanks
$16.5
Buy
13.95%
Upside
Reiterated
06/03/25
Ardent Health Partners, Inc. has a solid overall stock score driven by strong financial performance and positive corporate developments. While the technical analysis presents mixed signals, the company's strategic initiatives and undervaluation enhance its investment appeal. The earnings call and corporate events further support a positive outlook.
Bank of America Securities Analyst forecast on ARDT
Joanna GajukBank of America Securities
Bank of America Securities
Hold
Reiterated
05/16/25
Ardent Health Partners, Inc. (ARDT) Receives a Hold from Bank of America Securities
RBC Capital Analyst forecast on ARDT
Ben HendrixRBC Capital
RBC Capital
$21
Buy
45.03%
Upside
Reiterated
05/14/25
RBC Capital Reaffirms Their Buy Rating on Ardent Health Partners, Inc. (ARDT)
Guggenheim Analyst forecast on ARDT
Jason CassorlaGuggenheim
Guggenheim
$16$18
Buy
24.31%
Upside
Reiterated
05/09/25
Ardent Health price target raised to $18 from $16 at GuggenheimArdent Health price target raised to $18 from $16 at Guggenheim
Morgan Stanley Analyst forecast on ARDT
Craig HettenbachMorgan Stanley
Morgan Stanley
$22
Buy
51.93%
Upside
Reiterated
05/08/25
Morgan Stanley Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Leerink Partners Analyst forecast on ARDT
Whit MayoLeerink Partners
Leerink Partners
$21$24
Buy
65.75%
Upside
Reiterated
05/08/25
Ardent Health Partners, Inc. Shows Strong Q1 Performance with Growth Potential Amidst Strategic Opportunities
KeyBanc
Buy
Reiterated
05/08/25
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (NYSE: ARDT), Xencor (NASDAQ: XNCR) and LivaNova (NASDAQ: LIVN)
Truist Financial Analyst forecast on ARDT
David S MacdonaldTruist Financial
Truist Financial
Buy
Reiterated
05/07/25
Analysts Offer Insights on Healthcare Companies: Curis (NASDAQ: CRIS), Ardent Health Partners, Inc. (NYSE: ARDT) and Agilon Health (NYSE: AGL)
Mizuho Securities Analyst forecast on ARDT
Ann HynesMizuho Securities
Mizuho Securities
$19$18
Buy
24.31%
Upside
Reiterated
04/09/25
Ardent Health price target lowered to $18 from $19 at MizuhoArdent Health price target lowered to $18 from $19 at Mizuho
J.P. Morgan Analyst forecast on ARDT
Benjamin RossiJ.P. Morgan
J.P. Morgan
$20$18
Hold
24.31%
Upside
Reiterated
03/12/25
Ardent Health Partners, Inc. (ARDT) Receives a Hold from J.P. Morgan
Loop Capital Markets Analyst forecast on ARDT
Timothy GreavesLoop Capital Markets
Loop Capital Markets
$21
Buy
45.03%
Upside
Reiterated
01/08/25
Loop Capital Markets Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ARDT
TipRanks AITipRanks
Not Ranked
TipRanks
$16.5
Buy
13.95%
Upside
Reiterated
06/03/25
Ardent Health Partners, Inc. has a solid overall stock score driven by strong financial performance and positive corporate developments. While the technical analysis presents mixed signals, the company's strategic initiatives and undervaluation enhance its investment appeal. The earnings call and corporate events further support a positive outlook.
Bank of America Securities Analyst forecast on ARDT
Joanna GajukBank of America Securities
Bank of America Securities
Hold
Reiterated
05/16/25
Ardent Health Partners, Inc. (ARDT) Receives a Hold from Bank of America Securities
RBC Capital Analyst forecast on ARDT
Ben HendrixRBC Capital
RBC Capital
$21
Buy
45.03%
Upside
Reiterated
05/14/25
RBC Capital Reaffirms Their Buy Rating on Ardent Health Partners, Inc. (ARDT)
Guggenheim Analyst forecast on ARDT
Jason CassorlaGuggenheim
Guggenheim
$16$18
Buy
24.31%
Upside
Reiterated
05/09/25
Ardent Health price target raised to $18 from $16 at GuggenheimArdent Health price target raised to $18 from $16 at Guggenheim
Morgan Stanley Analyst forecast on ARDT
Craig HettenbachMorgan Stanley
Morgan Stanley
$22
Buy
51.93%
Upside
Reiterated
05/08/25
Morgan Stanley Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Leerink Partners Analyst forecast on ARDT
Whit MayoLeerink Partners
Leerink Partners
$21$24
Buy
65.75%
Upside
Reiterated
05/08/25
Ardent Health Partners, Inc. Shows Strong Q1 Performance with Growth Potential Amidst Strategic Opportunities
KeyBanc
Buy
Reiterated
05/08/25
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (NYSE: ARDT), Xencor (NASDAQ: XNCR) and LivaNova (NASDAQ: LIVN)
Truist Financial Analyst forecast on ARDT
David S MacdonaldTruist Financial
Truist Financial
Buy
Reiterated
05/07/25
Analysts Offer Insights on Healthcare Companies: Curis (NASDAQ: CRIS), Ardent Health Partners, Inc. (NYSE: ARDT) and Agilon Health (NYSE: AGL)
Mizuho Securities Analyst forecast on ARDT
Ann HynesMizuho Securities
Mizuho Securities
$19$18
Buy
24.31%
Upside
Reiterated
04/09/25
Ardent Health price target lowered to $18 from $19 at MizuhoArdent Health price target lowered to $18 from $19 at Mizuho
J.P. Morgan Analyst forecast on ARDT
Benjamin RossiJ.P. Morgan
J.P. Morgan
$20$18
Hold
24.31%
Upside
Reiterated
03/12/25
Ardent Health Partners, Inc. (ARDT) Receives a Hold from J.P. Morgan
Loop Capital Markets Analyst forecast on ARDT
Timothy GreavesLoop Capital Markets
Loop Capital Markets
$21
Buy
45.03%
Upside
Reiterated
01/08/25
Loop Capital Markets Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ardent Health Partners, Inc.

1 Month
xxx
Success Rate
3/7 ratings generated profit
43%
Average Return
-3.73%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of -3.73% per trade.
3 Months
xxx
Success Rate
3/8 ratings generated profit
38%
Average Return
-4.32%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of -4.32% per trade.
1 Year
Whit MayoLeerink Partners
Success Rate
2/8 ratings generated profit
25%
Average Return
-4.65%
reiterated a buy rating 27 days ago
Copying Whit Mayo's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -4.65% per trade.
2 Years
xxx
Success Rate
2/8 ratings generated profit
25%
Average Return
-4.65%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -4.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARDT Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
4
6
5
4
3
Buy
16
6
8
6
9
Hold
3
3
4
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
15
17
13
15
In the current month, ARDT has received 12 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. ARDT average Analyst price target in the past 3 months is 20.17.
Each month's total comprises the sum of three months' worth of ratings.

ARDT Financial Forecast

ARDT Earnings Forecast

Next quarter’s earnings estimate for ARDT is $0.58 with a range of $0.54 to $0.64. The previous quarter’s EPS was $0.29. ARDT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 40.00% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.
Next quarter’s earnings estimate for ARDT is $0.58 with a range of $0.54 to $0.64. The previous quarter’s EPS was $0.29. ARDT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 40.00% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.

ARDT Sales Forecast

Next quarter’s sales forecast for ARDT is $1.60B with a range of $1.56B to $1.63B. The previous quarter’s sales results were $1.50B. ARDT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 40.81% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.
Next quarter’s sales forecast for ARDT is $1.60B with a range of $1.56B to $1.63B. The previous quarter’s sales results were $1.50B. ARDT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 40.81% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.

ARDT Stock Forecast FAQ

What is ARDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Ardent Health Partners, Inc.’s 12-month average price target is 20.17.
    What is ARDT’s upside potential, based on the analysts’ average price target?
    Ardent Health Partners, Inc. has 39.30% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ARDT a Buy, Sell or Hold?
          Ardent Health Partners, Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Ardent Health Partners, Inc.’s price target?
            The average price target for Ardent Health Partners, Inc. is 20.17. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $24.00 ,the lowest forecast is $18.00. The average price target represents 39.30% Increase from the current price of $14.48.
              What do analysts say about Ardent Health Partners, Inc.?
              Ardent Health Partners, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of ARDT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis